Adagio Medical Holdings, Inc.

For the period ended Dec 31, 2024. Filed Mar 27, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 27, 2025

ADGM$1.92Day change unavailableStored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(in thousands, except share and per share data)


· · Successor · · · Predecessor
· December 31, · · December 31,
· · 2024 · · · 2023
Assets
Current assets:
Cash and cash equivalents	$20,586	$1,383
Accounts receivable, net	35	71
Inventory, net	2,566	3,322
Prepaid expenses	1,940	232
Other current assets	222	177
Total current assets	25,349	5,185
Property and equipment, net	1,961	1,487
Right-of-use assets, net	188	130
Intangible assets, net	6,969	—
Goodwill, net	13,967	—
Other assets	14	23
Total assets	$48,448	$6,825
Liabilities, convertible preferred stock, and stockholders’ equity (deficit)
Current liabilities:
Accounts payable	$2,840	$3,830
Accrued liabilities	3,673	3,048
Operating lease liabilities, current	143	79
Convertible notes payable, current	—	36,430
Warrant liabilities	—	78
Term loan, current	—	1,695
Accrued transaction costs	3	444
Other accrued liabilities	1,104	1,572
Total current liabilities	7,763	47,176
Operating lease liabilities, long-term	46	52
Convertible notes payable, non-current	16,076	—
Warrant liabilities	152	—
Deferred tax liabilities, net	883	—
Term loan, long-term	—	143
Other long-term liabilities	3,616	8
Total liabilities	28,536	47,379
Commitments and contingencies (Note 12)
Legacy Adagio's Convertible preferred stock, $0.001 par value; 4,939,946 shares authorized as of December 31, 2023; 4,939,946 shares issued and outstanding as of December 31, 2023, with aggregate liquidation preference of $91,637 as of December 31, 2023	—	91,469
Stockholders’ equity (deficit):
Legacy Adagio's common stock, $0.001 par value; 6,594,946 shares authorized as of December 31, 2023; 786,510 shares issued as of December 31, 2023; 779,908 shares outstanding as of December 31, 2023	—	1
Common stock, $0.0001 par value; 210,000,000 shares authorized as of December 31, 2024; 15,198,232 shares issued and outstanding as of December 31, 2024	2	—
Additional paid-in capital	90,495	1,608
Accumulated other comprehensive income	1	17
Accumulated deficit	(70,586)	(133,649)
Total stockholders’ equity (deficit)	19,912	(132,023)
Total liabilities, convertible preferred stock, and stockholders’ equity (deficit)	$48,448	$6,825

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.